Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis
<i>Background and Objectives</i>: Recently, a randomized controlled trial suggested a potential benefit of baricitinib in patients with diabetes mellitus, preserving β-cell function. However, the clinical evidence currently available is limited. We aimed to assess the potential impact of tofacitinib...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2024-02-01
|
| Reeks: | Medicina |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/1648-9144/60/3/360 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|